Chargement en cours...
(−)-Kusunokinin as a Potential Aldose Reductase Inhibitor: Equivalency Observed via AKR1B1 Dynamics Simulation
[Image: see text] (−)-Kusunokinin performed its anticancer potency through CFS1R and AKT pathways. Its ambiguous binding target has, however, hindered the next development phase. Our study thus applied molecular docking and molecular dynamics simulation to predict the protein target from the pathway...
Enregistré dans:
| Publié dans: | ACS Omega |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Chemical Society
2020
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7807751/ https://ncbi.nlm.nih.gov/pubmed/33458512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.0c05102 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|